Company

Cosmo BIO

コスモ・バイオ

3386 · TSE · Wholesale Trade

Financials Consolidated

Revenue¥10.8bn+7.3% year on yearConsolidated · FY12/25

Ordinary profit¥489m+34.3% year on yearConsolidated · FY12/25

Net profit¥337m+28.6% year on yearConsolidated · FY12/25

Dividend per share¥50.00FY12/25

Revenue

¥9.23bnFY12/21

¥9.55bnFY12/22

¥9.34bnFY12/23

¥10.0bnFY12/24

¥10.8bnFY12/25

Ordinary profit

¥1.10bnFY12/21

¥790mFY12/22

¥653mFY12/23

¥364mFY12/24

¥489mFY12/25

Net profit (attributable)

¥737mFY12/21

¥517mFY12/22

¥442mFY12/23

¥262mFY12/24

¥337mFY12/25

Op. cash flow

¥648mFY12/21

¥284mFY12/22

¥736mFY12/23

¥241mFY12/24

¥595mFY12/25

Employees, whole group182 peopleFY12/25

Employees, parent company (non-consolidated)144 peopleFY12/25

Average salary¥6.65mFY12/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history

Five-year history
Fiscal year	Revenue	Ordinary profit	Net profit (attributable)	EPS	Dividend	Total assets	Net assets	Op. cash flow
FY12/25	¥10.77bn+7.3% year on year	¥489m	¥337m	¥59.26	¥50.00	¥12.7bn	¥9.96bn	¥595m
FY12/24	¥10.04bn+7.5% year on year	¥364m	¥262m	¥45.05	¥50.00	¥11.7bn	¥9.56bn	¥241m
FY12/23	¥9.34bn−2.2% year on year	¥653m	¥442m	¥75.97	¥30.00	¥10.9bn	¥9.03bn	¥736m
FY12/22	¥9.55bn+3.5% year on year	¥790m	¥517m	¥89.13	¥36.00	¥10.3bn	¥8.62bn	¥284m
FY12/21	¥9.23bn	¥1,099m	¥737m	¥126.94	¥36.00	¥10.1bn	¥8.32bn	¥648m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XRR0 · Japan GAAP. Each figure's years come from one report's five-year summary.